There May Be Some Bright Spots In Yuhan's (KRX:000100) Earnings
Mar 19
Have your own idea? Try our Stock Screener
South Korean (KOSPI) Pharma Industry Analysis
UpdatedMar 23, 2025
DataAggregated Company Financials
Companies102
- 7D-2.1%
- 3M2.4%
- 1Y-4.8%
- YTDn/a
Over the last 7 days, the Pharma industry has dropped 2.1%, driven by declines in Hanall Biopharma and Yuhan of 18% and 2.9%, respectively. In contrast, Mezzion PharmaLtd has gained 6.2%. Overall the industry is down 4.8% in 12 months. Earnings are forecast to grow by 27% annually.
Industry Valuation and Performance
Has the South Korean Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sun, 23 Mar 2025 | ₩53.8t | ₩29.7t | ₩993.0b | 13.9x | 54.1x | 1.8x |
| Tue, 18 Feb 2025 | ₩56.7t | ₩29.5t | ₩1.0t | 11.8x | 56.5x | 1.9x |
| Thu, 16 Jan 2025 | ₩55.7t | ₩29.6t | ₩1.0t | 12.9x | 54.8x | 1.9x |
| Sat, 14 Dec 2024 | ₩52.5t | ₩29.4t | ₩994.3b | 11.8x | 52.8x | 1.8x |
| Mon, 11 Nov 2024 | ₩58.2t | ₩28.7t | ₩841.1b | 15x | 69.2x | 2x |
| Wed, 09 Oct 2024 | ₩59.8t | ₩28.7t | ₩833.2b | 15.1x | 71.7x | 2.1x |
| Fri, 06 Sep 2024 | ₩56.5t | ₩28.8t | ₩838.0b | 15.3x | 67.4x | 2x |
| Sun, 04 Aug 2024 | ₩53.7t | ₩28.4t | ₩762.2b | 14x | 70.4x | 1.9x |
| Tue, 02 Jul 2024 | ₩53.7t | ₩29.7t | ₩882.3b | 13.6x | 60.8x | 1.8x |
| Thu, 30 May 2024 | ₩51.6t | ₩30.2t | ₩897.0b | 13.7x | 57.5x | 1.7x |
| Sat, 27 Apr 2024 | ₩50.9t | ₩29.4t | ₩922.9b | 16.6x | 55.2x | 1.7x |
| Mon, 25 Mar 2024 | ₩55.5t | ₩30.1t | ₩890.9b | 21.4x | 62.3x | 1.8x |
| Wed, 21 Feb 2024 | ₩52.4t | ₩29.6t | ₩593.1b | 21.1x | 88.3x | 1.8x |
| Fri, 19 Jan 2024 | ₩51.4t | ₩29.6t | ₩592.3b | 22.4x | 86.7x | 1.7x |
| Sun, 17 Dec 2023 | ₩50.6t | ₩29.6t | ₩588.2b | 21.5x | 86x | 1.7x |
| Tue, 14 Nov 2023 | ₩48.3t | ₩29.3t | ₩683.4b | 16.2x | 70.7x | 1.6x |
| Thu, 12 Oct 2023 | ₩51.1t | ₩29.3t | ₩683.3b | 17.2x | 74.8x | 1.7x |
| Sat, 09 Sep 2023 | ₩51.4t | ₩29.3t | ₩683.9b | 16.4x | 75.2x | 1.8x |
| Mon, 07 Aug 2023 | ₩51.8t | ₩28.8t | ₩884.1b | 22.2x | 58.6x | 1.8x |
| Wed, 05 Jul 2023 | ₩47.3t | ₩28.8t | ₩899.2b | 20.4x | 52.6x | 1.6x |
| Fri, 02 Jun 2023 | ₩48.6t | ₩28.9t | ₩913.0b | 23.1x | 53.2x | 1.7x |
| Sun, 30 Apr 2023 | ₩47.7t | ₩28.5t | ₩602.7b | 20.9x | 79.1x | 1.7x |
| Tue, 28 Mar 2023 | ₩44.7t | ₩28.3t | ₩655.8b | 21.6x | 68.1x | 1.6x |
| Thu, 23 Feb 2023 | ₩44.6t | ₩27.7t | ₩743.5b | 20.4x | 60x | 1.6x |
| Sat, 21 Jan 2023 | ₩44.9t | ₩28.0t | ₩770.2b | 19.7x | 58.3x | 1.6x |
| Mon, 19 Dec 2022 | ₩47.7t | ₩28.0t | ₩770.2b | 20.1x | 61.9x | 1.7x |
| Wed, 16 Nov 2022 | ₩46.9t | ₩27.3t | ₩701.8b | 20.8x | 66.8x | 1.7x |
| Fri, 14 Oct 2022 | ₩39.3t | ₩27.2t | ₩694.8b | 19x | 56.6x | 1.4x |
| Sun, 11 Sep 2022 | ₩47.6t | ₩27.5t | ₩725.8b | 21.8x | 65.6x | 1.7x |
| Tue, 09 Aug 2022 | ₩52.4t | ₩26.7t | ₩475.9b | 23.4x | 110.1x | 2x |
| Thu, 07 Jul 2022 | ₩48.4t | ₩26.7t | ₩475.9b | 20.6x | 101.8x | 1.8x |
| Sat, 04 Jun 2022 | ₩53.8t | ₩26.7t | ₩477.5b | 24.1x | 112.7x | 2x |
| Mon, 02 May 2022 | ₩57.0t | ₩26.1t | ₩674.3b | 27.3x | 84.5x | 2.2x |
| Wed, 30 Mar 2022 | ₩57.0t | ₩25.9t | ₩739.5b | 26.3x | 77.1x | 2.2x |
Price to Earnings Ratio
77.1x
Current Industry PE
- Investors are pessimistic on the South Korean Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 54.1x which is lower than its 3-year average PE of 70.3x.
- The industry is trading close to its 3-year average PS ratio of 1.8x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have grown 10% per year over the last three years.
- Revenues for these companies have grown 4.6% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Comparison
How does South Korean Pharma compare with similar industries?
| KR Market | 2.23% | |
| Healthcare | -1.56% | |
| Pharma | -2.14% | |
| Pharma | -2.14% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| A140410 Mezzion PharmaLtd | ₩29.20k | 6.2% +₩50.9b | -31.9% | PS101.6x | |
| A200670 Humedix | ₩42.00k | 7.1% +₩28.9b | 46.6% | n/a | |
| A068760 Celltrion Pharm | ₩53.90k | 0.9% +₩21.7b | -50.5% | n/a | |
| A271980 Jeil PharmaceuticalLtd | ₩11.44k | 9.5% +₩14.4b | -32.3% | PS0.2x | |
| A185750 Chong Kun Dang Pharmaceutical | ₩80.20k | 1.1% +₩11.9b | -23.0% | PE9.7x |
